Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

4.465 -1.765 (-28.33%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,682,555
Open 3.900
Bid (Size) 4.400 (400)
Ask (Size) 4.530 (12,700)
Prev. Close 6.230
Today's Range 3.401 - 4.501
52wk Range 3.401 - 10.79
Shares Outstanding 61,331,465
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Nasdaq Tumbles Over 100 Points; US Consumer Sentiment Falls In November
 
Via Benzinga

Performance

YTD
-43.3%
-43.3%
1 Month
-27.5%
-27.5%
3 Month
-27.2%
-27.2%
6 Month
-34.5%
-34.5%
1 Year
-43.5%
-43.5%

More News

Read More
What's going on in today's session
Via Chartmill
Keep an eye on the top gainers and losers in Friday's session.
Via Chartmill
Earnings Scheduled For November 6, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Treace Medical (TMCI) Q3 2025 Earnings Transcript
Via The Motley Fool
These stocks are gapping in today's session
Via Chartmill
Discover the top movers in Friday's pre-market session.
Via Chartmill
Treace Announces Participation in Two Upcoming Investor Conferences
From Treace Medical Concepts, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Block Posts Downbeat Q3 Results, Joins Archer Aviation, DraftKings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Treace Medical Concepts Inc (NASDAQ:TMCI) Stock Plummets 27% After Slashing 2025 Revenue Outlook
Via Chartmill
What's going on in today's after hours session
Via Chartmill
Treace Medical Concepts Reports Third Quarter 2025 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Treace Medical Concepts (NASDAQ: TMCI): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); Treace Medical Concepts (NASDAQ: TMCI); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Five Below, Inc. (NASDAQ: FIVE); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Five Below, Inc. (NASDAQ: FIVE); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Fluor Corporation (NYSE: FLR); RCI Hospitality Holdings, Inc. (NASDAQ: RICK); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); LuxUrban Hotels Inc. (OTC: LUXH); RCI Hospitality Holdings, Inc. (NASDAQ: RICK); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating
From Grabar Law Office
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Ibotta Inc. (NYSE: IBTA); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your
From Grabar Law Office
Via GlobeNewswire
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Important Notice to Long-Term Shareholders of Flywire Corporation (NASDAQ: FLYW); Ibotta, Inc. (NYSE: IBTA); SelectQuote, Inc. (NYSE: SLQT); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire

Frequently Asked Questions

Is Treace Medical Concepts, Inc. - Common Stock publicly traded?
Yes, Treace Medical Concepts, Inc. - Common Stock is publicly traded.
What exchange does Treace Medical Concepts, Inc. - Common Stock trade on?
Treace Medical Concepts, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Treace Medical Concepts, Inc. - Common Stock?
The ticker symbol for Treace Medical Concepts, Inc. - Common Stock is TMCI on the Nasdaq Stock Market
What is the current price of Treace Medical Concepts, Inc. - Common Stock?
The current price of Treace Medical Concepts, Inc. - Common Stock is 4.465
When was Treace Medical Concepts, Inc. - Common Stock last traded?
The last trade of Treace Medical Concepts, Inc. - Common Stock was at 11/07/25 04:00 PM ET
What is the market capitalization of Treace Medical Concepts, Inc. - Common Stock?
The market capitalization of Treace Medical Concepts, Inc. - Common Stock is 273.84M
How many shares of Treace Medical Concepts, Inc. - Common Stock are outstanding?
Treace Medical Concepts, Inc. - Common Stock has 274M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.